Advising and investing in autoimmune companies to improve patient outcomes and drive growth. Analysis and strategy based on experience: seed stage digital health co-founder, 10+ years patient advocate, 14+ years Wall Street analyst.
Our Vision: A world where people with chronic immunoinflammatory conditions get the best care possible, drawing on conventional, digital and functional medicine.
Our Mission: To raise awareness of CIID, autoimmune and related conditions and to use our expertise to advance companies working to improve research, diagnostics and clinical care for this community.
Our Business: We provide strategic advisory services to emerging and established companies and organizations across the autoimmune ecosystem that share our mission to improve patient outcomes.
For Businesses –
We help autoimmune-focused companies align capital, strategy, and care delivery around lasting patient impact.
About Us –
An invisible epidemic as costly as cancer or heart disease lurks among us. From autoimmune to long COVID, tens of millions of people suffer chronic immunoinflammatory diseases (CIIDs) too often overlooked and underserved by current healthcare systems. Let us help you change that through our understanding of how CIIDs affect payers, providers, and patients, and how emerging innovation can translate into better outcomes and care.
Subject Matter Expertise –
We like staying up to date on the latest players in digital health. In this series, we interview the founders of some of the up-and-coming digital health agencies, learning about their vision, background, and strategy.
Get in Touch
